MetaADEDB 2.0 @ LMMD
Iohexol
(NTHXOOBQLCIOLC-UHFFFAOYSA-N)
Structure
SMILES
OCC(CN(c1c(I)c(C(=O)NCC(CO)O)c(c(c1I)C(=O)NCC(CO)O)I)C(=O)C)O
Type(s)
Approved
ATC code(s)
V08AB02
Molecular Formula:
C19H26I3N3O9
Molecular Weight:
821.138
Log P:
-0.8457
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
8
TPSA:
199.89
CAS Number(s):
66108-95-0
Synonym(s)
1.
Iohexol
2.
Compound 545
3.
Exypaque
4.
Iohexol 350
5.
Nycodenz
6.
Omnipaque
External Link(s)
MeSHD007472
PubChem Compound3730
BindingDB50247977
ChEBI31709
CHEMBLCHEMBL1200455
DrugBankDB01362
DrugCentral1461
KEGGdr:D01817
Therapeutic Target DatabaseD02BLO
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1UrticariaFAERS: 560
Canada Vigilance: 1126
8213508CTD
SIDER
Canada Vigilance
US FAERS
2PruritusFAERS: 399
Canada Vigilance: 439
8213508CTD
SIDER
Canada Vigilance
US FAERS
3ErythemaFAERS: 303
Canada Vigilance: 120
Canada Vigilance
SIDER
US FAERS
4NauseaFAERS: 205
Canada Vigilance: 63
2217792
8213508
CTD
SIDER
Canada Vigilance
US FAERS
5VomitingFAERS: 192
Canada Vigilance: 63
2217792
8213508
CTD
SIDER
Canada Vigilance
US FAERS
6SneezingFAERS: 160
Canada Vigilance: 139
Canada Vigilance
US FAERS
7ChillsFAERS: 154
Canada Vigilance: 8
Canada Vigilance
US FAERS
8Contrast media reactionFAERS: 154
Canada Vigilance: 32
Canada Vigilance
SIDER
US FAERS
9ExtravasationFAERS: 127SIDER
US FAERS
10HypersensitivityFAERS: 117
Canada Vigilance: 53
Canada Vigilance
SIDER
US FAERS
11HypotensionFAERS: 99
Canada Vigilance: 17
3588918
8213508
CTD
SIDER
Canada Vigilance
US FAERS
12Throat irritationFAERS: 99
Canada Vigilance: 90
Canada Vigilance
US FAERS
13HeadacheFAERS: 97
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
14Chest discomfortFAERS: 92
Canada Vigilance: 38
Canada Vigilance
US FAERS
15DizzinessFAERS: 82
Canada Vigilance: 25
Canada Vigilance
SIDER
US FAERS
16Anaphylactoid ReactionFAERS: 72
Canada Vigilance: 25
Canada Vigilance
SIDER
US FAERS
17Contrast media allergyFAERS: 65
Canada Vigilance: 18
Canada Vigilance
US FAERS
18Chest PainFAERS: 57
Canada Vigilance: 18
Canada Vigilance
US FAERS
19MalaiseFAERS: 57
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
20TachycardiaFAERS: 56
Canada Vigilance: 5
1889431
19159858
CTD
Canada Vigilance
US FAERS
21No adverse eventFAERS: 54US FAERS
22FlushingFAERS: 52
Canada Vigilance: 32
Canada Vigilance
SIDER
US FAERS
23Anaphylactic shockFAERS: 50
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
24TremorFAERS: 46
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
25Cardiac ArrestFAERS: 39
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
26ShockFAERS: 383588918CTD
SIDER
US FAERS
27Injection site extravasationFAERS: 35US FAERS
28PainFAERS: 35
Canada Vigilance: 4

View details

CTD
SIDER
Canada Vigilance
US FAERS
29Lip swellingFAERS: 34
Canada Vigilance: 25
Canada Vigilance
US FAERS
30Respiratory arrestFAERS: 34
Canada Vigilance: 4
Canada Vigilance
US FAERS
31WheezingFAERS: 34
Canada Vigilance: 11
Canada Vigilance
US FAERS
32Respiratory distressFAERS: 33
Canada Vigilance: 5
Canada Vigilance
US FAERS
33SwellingFAERS: 33
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
34Infusion Site ExtravasationFAERS: 32US FAERS
35CyanosisFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
36AngioedemaFAERS: 29
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
37Unresponsive to stimuliFAERS: 29
Canada Vigilance: 8
Canada Vigilance
OFFSIDES
US FAERS
38AstheniaFAERS: 28
Canada Vigilance: 4
Canada Vigilance
US FAERS
39Back PainFAERS: 28
Canada Vigilance: 2
Canada Vigilance
US FAERS
40BronchospasmFAERS: 27
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
41PapuleFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Depressed Level of ConsciousnessFAERS: 26
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
43DysphoniaFAERS: 25
Canada Vigilance: 14
Canada Vigilance
US FAERS
44PalpitationsFAERS: 25
Canada Vigilance: 3
Canada Vigilance
US FAERS
45Feeling abnormalFAERS: 24
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
46Injection site painFAERS: 24
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
47Post procedural complicationFAERS: 24OFFSIDES
US FAERS
48Rash erythematousFAERS: 24
Canada Vigilance: 16
Canada Vigilance
US FAERS
49Abdominal PainFAERS: 231848715CTD
SIDER
US FAERS
50PallorFAERS: 23
Canada Vigilance: 5
Canada Vigilance
US FAERS
51SyncopeFAERS: 23
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
52Burning sensationFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
53MyalgiaFAERS: 21US FAERS
54Acute kidney injuryFAERS: 20

View details

CTD
US FAERS
55Drug ineffectiveFAERS: 20US FAERS
56BradycardiaFAERS: 19
Canada Vigilance: 1

View details

CTD
SIDER
Canada Vigilance
US FAERS
57FatigueFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
58Ventricular FibrillationFAERS: 18

View details

CTD
US FAERS
59Blood creatinine increasedFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
60Peripheral swellingFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
61AphasiaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
62Product quality issueFAERS: 16US FAERS
63Neck PainFAERS: 15
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
64Skin reactionFAERS: 15
Canada Vigilance: 3
Canada Vigilance
US FAERS
65AnxietyFAERS: 14
Canada Vigilance: 5
Canada Vigilance
US FAERS
66DiscomfortFAERS: 14
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
67Myocardial InfarctionFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
68PancreatitisFAERS: 14SIDER
US FAERS
69RetchingFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
70ArthralgiaFAERS: 13
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
71Feeling ColdFAERS: 13
Canada Vigilance: 4
Canada Vigilance
US FAERS
72Respiratory FailureFAERS: 13US FAERS
73DisorientationFAERS: 12
Canada Vigilance: 5
Canada Vigilance
US FAERS
74Eye irritationFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
75SomnolenceFAERS: 12
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
76Abdominal discomfortFAERS: 11
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
77AgitationFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
78ArachnoiditisFAERS: 11US FAERS
79Cold sweatFAERS: 11
Canada Vigilance: 3
Canada Vigilance
US FAERS
80PneumothoraxFAERS: 11US FAERS
81Blood urea increasedFAERS: 10OFFSIDES
US FAERS
82PetechiaeFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
83Procedural complicationFAERS: 10OFFSIDES
US FAERS
84BlindnessFAERS: 9US FAERS
85Blood pressure immeasurableFAERS: 9OFFSIDES
US FAERS
86Erythema MultiformeFAERS: 9OFFSIDES
US FAERS
87Musculoskeletal stiffnessFAERS: 9
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
88Oral pruritusFAERS: 9
Canada Vigilance: 10
Canada Vigilance
US FAERS
89Oropharyngeal painFAERS: 9
Canada Vigilance: 7
Canada Vigilance
US FAERS
90Disseminated Intravascular CoagulationFAERS: 87752347CTD
OFFSIDES
US FAERS
91MeningitisFAERS: 8
Canada Vigilance: 2
2027457
3545637
CTD
Canada Vigilance
US FAERS
92IndurationFAERS: 7US FAERS
93Pharmaceutical product complaintFAERS: 7OFFSIDES
US FAERS
94Renal tubular necrosisFAERS: 7US FAERS
95RestlessnessFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
96Tongue pruritusFAERS: 7
Canada Vigilance: 6
Canada Vigilance
US FAERS
97Urinary IncontinenceFAERS: 7US FAERS
98Alanine Aminotransferase IncreasedFAERS: 6US FAERS
99DysgeusiaFAERS: 6SIDER
US FAERS
100Hypertensive crisisFAERS: 6US FAERS
101LethargyFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
102Nasal pruritusFAERS: 6
Canada Vigilance: 7
Canada Vigilance
US FAERS
103PresyncopeFAERS: 6
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
104Septic ShockFAERS: 6US FAERS
105Aspartate Aminotransferase IncreasedFAERS: 5US FAERS
106Atrial FibrillationFAERS: 5US FAERS
107DehydrationFAERS: 5US FAERS
108DeliriumFAERS: 5US FAERS
109DiplegiaFAERS: 5US FAERS
110DysarthriaFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
111EczemaFAERS: 5US FAERS
112HyperthyroidismFAERS: 5SIDER
US FAERS
113HypoxiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
114Occupational exposure to productFAERS: 5US FAERS
115Oropharyngeal discomfortFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
116Pulmonary EmbolismFAERS: 5US FAERS
117Unevaluable eventFAERS: 5US FAERS
118VertigoFAERS: 5US FAERS
119AbscessFAERS: 4US FAERS
120Accidental exposure to productFAERS: 4US FAERS
121AcidosisFAERS: 415261325CTD
OFFSIDES
US FAERS
122AcneFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
123Air EmbolismFAERS: 4US FAERS
124Altered state of consciousnessFAERS: 4US FAERS
125AsthmaFAERS: 4US FAERS
126Cerebrovascular accidentFAERS: 4US FAERS
127ChokingFAERS: 4
Canada Vigilance: 6
Canada Vigilance
US FAERS
128Drug administration errorFAERS: 4US FAERS
129DysuriaFAERS: 4US FAERS
130Eye painFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
131General physical health deteriorationFAERS: 4US FAERS
132HemiparesisFAERS: 4US FAERS
133HemiplegiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
134Incorrect route of drug administrationFAERS: 4US FAERS
135Injection site abscessFAERS: 4US FAERS
136LaryngospasmFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
137LeukocytosisFAERS: 4US FAERS
138Mouth swellingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
139QuadriplegiaFAERS: 4US FAERS
140RhabdomyolysisFAERS: 415153217CTD
US FAERS
141SepsisFAERS: 4US FAERS
142Sinus TachycardiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
143Status EpilepticusFAERS: 43396204
8492906
CTD
OFFSIDES
US FAERS
144Sudden deathFAERS: 4OFFSIDES
US FAERS
145VasospasmFAERS: 4US FAERS
146Acute myocardial infarctionFAERS: 3US FAERS
147Acute respiratory failureFAERS: 3US FAERS
148AnuriaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
149Blood brain barrier defectFAERS: 3OFFSIDES
US FAERS
150Blood pressure fluctuationFAERS: 3US FAERS
151CandidiasisFAERS: 3US FAERS
152Cardiac procedure complicationFAERS: 3US FAERS
153Cerebral disorderFAERS: 3US FAERS
154Choking sensationFAERS: 3US FAERS
155Conversion disorderFAERS: 3OFFSIDES
US FAERS
156DermatitisFAERS: 3SIDER
US FAERS
157Documented hypersensitivity to administered productFAERS: 3US FAERS
158Drug exposure during pregnancyFAERS: 3US FAERS
159Ear discomfortFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
160EpistaxisFAERS: 3OFFSIDES
US FAERS
161Expired product administeredFAERS: 3US FAERS
162IncontinenceFAERS: 3US FAERS
163Increased upper airway secretionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
164InfectionFAERS: 3US FAERS
165Infusion site swellingFAERS: 3US FAERS
166Injection Site ReactionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
167Injection related reactionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
168Injection site erythemaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
169Injection site pruritusFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
170Injection site vesiclesFAERS: 3US FAERS
171Kounis SyndromeFAERS: 3US FAERS
172Laryngeal discomfortFAERS: 3US FAERS
173Livedo ReticularisFAERS: 3US FAERS
174Multiple use of single-use productFAERS: 3US FAERS
175Nerve injuryFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
176Oropharyngeal swellingFAERS: 3OFFSIDES
US FAERS
177OsteomyelitisFAERS: 3US FAERS
178PneumoniaFAERS: 3US FAERS
179Post procedural infectionFAERS: 3US FAERS
180Productive CoughFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
181Retrograde amnesiaFAERS: 3US FAERS
182Skin tightnessFAERS: 3US FAERS
183Temperature intoleranceFAERS: 3US FAERS
184ThirstFAERS: 3US FAERS
185Urinary RetentionFAERS: 3US FAERS
186Venous intravasationFAERS: 3US FAERS
187Vulvovaginal pruritusFAERS: 3US FAERS
188AbasiaFAERS: 2US FAERS
189Acute Coronary SyndromeFAERS: 2US FAERS
190AmnesiaFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
191AnorexiaFAERS: 2US FAERS
192AscitesFAERS: 2US FAERS
193AsphyxiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
194Blood creatine phosphokinase increasedFAERS: 2US FAERS
195Blood electrolytes abnormalFAERS: 2OFFSIDES
US FAERS
196Blood glucose increasedFAERS: 2US FAERS
197Blood lactate dehydrogenase increasedFAERS: 2OFFSIDES
US FAERS
198Blood potassium increasedFAERS: 2US FAERS
199ClaustrophobiaFAERS: 2US FAERS
200CystFAERS: 2US FAERS
201DeafnessFAERS: 2US FAERS
202DemyelinationFAERS: 2US FAERS
203Documented hypersensitivity to administered drugFAERS: 2US FAERS
204DysphemiaFAERS: 2US FAERS
205Electrocardiogram ST segment abnormalFAERS: 2US FAERS
206Emotional distressFAERS: 2US FAERS
207EpilepsyFAERS: 2US FAERS
208Facial paralysisFAERS: 2US FAERS
209Fixed drug eruptionFAERS: 2US FAERS
210Foaming at mouthFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
211Food AllergyFAERS: 2US FAERS
212Gastrointestinal infectionFAERS: 2US FAERS
213Global AmnesiaFAERS: 2OFFSIDES
US FAERS
214GlossitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
215HepatosplenomegalyFAERS: 2OFFSIDES
US FAERS
216Hyporesponsive to stimuliFAERS: 2US FAERS
217HypoventilationFAERS: 2US FAERS
218Iatrogenic injuryFAERS: 2US FAERS
219IncoherentFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
220InflammationFAERS: 2US FAERS
221Infusion site erythemaFAERS: 2US FAERS
222Infusion site painFAERS: 2US FAERS
223Injection site stingingFAERS: 2US FAERS
224Iodine allergyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
225Joint swellingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
226Larynx irritationFAERS: 2US FAERS
227Low birth weight babyFAERS: 2US FAERS
228Memory impairmentFAERS: 2US FAERS
229Metabolic acidosisFAERS: 2US FAERS
230MyoclonusFAERS: 215153217CTD
US FAERS
231NervousnessFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
232NeuralgiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
233Neurological examination abnormalFAERS: 2US FAERS
234NystagmusFAERS: 2US FAERS
235ParaplegiaFAERS: 21672026CTD
US FAERS
236RalesFAERS: 2US FAERS
237Respiratory DepressionFAERS: 2US FAERS
238Shoulder PainFAERS: 2US FAERS
239Skin hypertrophyFAERS: 2OFFSIDES
US FAERS
240Skin lesionFAERS: 2US FAERS
241StressFAERS: 2US FAERS
242ThrombosisFAERS: 2

View details

CTD
SIDER
US FAERS
243TinnitusFAERS: 2US FAERS
244Toxic Epidermal NecrolysisFAERS: 2US FAERS
245Urinary tract infectionFAERS: 2US FAERS
246Visual ImpairmentFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
247Vulvovaginal painFAERS: 2US FAERS
248YawningFAERS: 2US FAERS
249Abdominal sepsisFAERS: 1US FAERS
250Accidental overdoseFAERS: 1US FAERS
251Acinetobacter test positiveFAERS: 1US FAERS
252AgnosiaFAERS: 1US FAERS
253Agonal death struggleFAERS: 1US FAERS
254AlopeciaFAERS: 1US FAERS
255Anal discomfortFAERS: 1US FAERS
256Anal sphincter atonyFAERS: 1US FAERS
257AngerFAERS: 1US FAERS
258AphoniaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
259AppendicitisFAERS: 1US FAERS
260AsthenopiaFAERS: 1US FAERS
261Atrioventricular BlockFAERS: 116518532CTD
US FAERS
262Biopsy skin abnormalFAERS: 1US FAERS
263Blood alkaline phosphatase increasedFAERS: 1US FAERS
264Blood creatinine decreasedFAERS: 1US FAERS
265Blood sodium decreasedFAERS: 1US FAERS
266Blood thyroid stimulating hormone decreasedFAERS: 1US FAERS
267Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
268Blood urine presentFAERS: 1US FAERS
269Bone swellingFAERS: 1US FAERS
270Brain scan abnormalFAERS: 1US FAERS
271BronchitisFAERS: 1US FAERS
272Cardiac TamponadeFAERS: 12306916CTD
US FAERS
273Cardiac discomfortFAERS: 1US FAERS
274Cardiovascular insufficiencyFAERS: 1US FAERS
275Carotid Artery ThrombosisFAERS: 1US FAERS
276Catheter site related reactionFAERS: 1US FAERS
277Cauda Equina SyndromeFAERS: 1US FAERS
278Cerebral InfarctionFAERS: 1US FAERS
279Cervical myelopathyFAERS: 1US FAERS
280Chemical burn of skinFAERS: 1US FAERS
281Cholestatic liver injuryFAERS: 1US FAERS
282Citrobacter infectionFAERS: 1US FAERS
283Clostridium colitisFAERS: 1US FAERS
284Coma scale abnormalFAERS: 1US FAERS
285ConfabulationFAERS: 1US FAERS
286ConstipationFAERS: 1US FAERS
287Contrast encephalopathyFAERS: 1US FAERS
288Contrast media depositionFAERS: 1US FAERS
289Coronary artery embolismFAERS: 1US FAERS
290CryingFAERS: 1US FAERS
291CystitisFAERS: 1US FAERS
292Depressed moodFAERS: 1US FAERS
293DiapedesisFAERS: 1US FAERS
294Disease ProgressionFAERS: 1US FAERS
295DroolingFAERS: 1US FAERS
296Drug level increasedFAERS: 1US FAERS
297Drug prescribing errorFAERS: 1US FAERS
298Drug toxicityFAERS: 1US FAERS
299DysgraphiaFAERS: 1US FAERS
300DysphasiaFAERS: 1US FAERS
301Ear congestionFAERS: 1US FAERS
302Electroencephalogram abnormalFAERS: 1SIDER
US FAERS
303EncephalitisFAERS: 1US FAERS
304EndocarditisFAERS: 1US FAERS
305Enlarged uvulaFAERS: 1US FAERS
306Epigastric discomfortFAERS: 1US FAERS
307ExophthalmosFAERS: 1US FAERS
308Exposure to toxic agentFAERS: 1US FAERS
309Eyelid rashFAERS: 1US FAERS
310Eyelids pruritusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
311FasciectomyFAERS: 1US FAERS
312FibrosisFAERS: 1US FAERS
313Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
314GranulomaFAERS: 1US FAERS
315Grip strength decreasedFAERS: 1US FAERS
316Hair injuryFAERS: 1US FAERS
317Head discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
318Hepatitis AFAERS: 1US FAERS
319HerniaFAERS: 1US FAERS
320Histamine level increasedFAERS: 1US FAERS
321HyperpyrexiaFAERS: 1US FAERS
322Immediate post-injection reactionFAERS: 1
Canada Vigilance: 9
Canada Vigilance
US FAERS
323Impaired driving abilityFAERS: 1US FAERS
324Incorrect dose administeredFAERS: 1US FAERS
325Infrequent bowel movementsFAERS: 1US FAERS
326Injected limb mobility decreasedFAERS: 1US FAERS
327Injection site bruisingFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
328Injection site infectionFAERS: 1US FAERS
329Injection site inflammationFAERS: 1OFFSIDES
US FAERS
330Injection site injuryFAERS: 1OFFSIDES
US FAERS
331Injection site necrosisFAERS: 1US FAERS
332Injection site scarFAERS: 1US FAERS
333Injection site thrombosisFAERS: 1US FAERS
334Intestinal angioedemaFAERS: 1US FAERS
335Irritable Bowel SyndromeFAERS: 1US FAERS
336Joint abscessFAERS: 1US FAERS
337Joint stiffnessFAERS: 1OFFSIDES
US FAERS
338Labile blood pressureFAERS: 1US FAERS
339Laboratory test interferenceFAERS: 1US FAERS
340Laryngeal ObstructionFAERS: 1US FAERS
341LeukoencephalomyelitisFAERS: 1US FAERS
342LeukopeniaFAERS: 1US FAERS
343Lip erosionFAERS: 1US FAERS
344LividityFAERS: 1US FAERS
345Lung InjuryFAERS: 1US FAERS
346Lung consolidationFAERS: 1US FAERS
347LymphadenopathyFAERS: 1US FAERS
348Mental status changesFAERS: 1US FAERS
349Migration of implantFAERS: 1US FAERS
350MonoplegiaFAERS: 1US FAERS
351Muscle RigidityFAERS: 1US FAERS
352Muscle tightnessFAERS: 1US FAERS
353Musculoskeletal PainFAERS: 1US FAERS
354Nasal discomfortFAERS: 1US FAERS
355NecrosisFAERS: 1US FAERS
356NephritisFAERS: 1US FAERS
357No reaction on previous exposure to drugFAERS: 1US FAERS
358Nuchal RigidityFAERS: 1US FAERS
359Ocular discomfortFAERS: 1US FAERS
360Oculomucocutaneous syndromeFAERS: 1US FAERS
361OpisthotonusFAERS: 1US FAERS
362Optic NeuropathyFAERS: 1US FAERS
363Oral candidiasisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
364Oral mucosal eruptionFAERS: 1US FAERS
365OverdoseFAERS: 1US FAERS
366Pain of skinFAERS: 1OFFSIDES
US FAERS
367Paraspinal abscessFAERS: 1US FAERS
368ParotitisFAERS: 1US FAERS
369Patient-device incompatibilityFAERS: 1US FAERS
370Penile swellingFAERS: 1US FAERS
371Periorbital swellingFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
372Peritoneal fluid analysis abnormalFAERS: 1US FAERS
373PeritonitisFAERS: 1US FAERS
374PhlebitisFAERS: 12217792CTD
US FAERS
375Pneumatosis Cystoides IntestinalisFAERS: 1US FAERS
376PolyuriaFAERS: 1US FAERS
377Poor peripheral circulationFAERS: 1US FAERS
378Poor quality drug administeredFAERS: 1US FAERS
379Post lumbar puncture syndromeFAERS: 1US FAERS
380Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
381Postoperative infectionFAERS: 1US FAERS
382Product contaminationFAERS: 1US FAERS
383Product label confusionFAERS: 1US FAERS
384Product physical issueFAERS: 1US FAERS
385Pulmonary vascular disorderFAERS: 1US FAERS
386Pustular psoriasisFAERS: 1OFFSIDES
US FAERS
387Red man syndromeFAERS: 1US FAERS
388RegurgitationFAERS: 1US FAERS
389Renal ColicFAERS: 1US FAERS
390Renal tubular disorderFAERS: 1OFFSIDES
US FAERS
391Respiratory tract infection fungalFAERS: 1US FAERS
392RhonchiFAERS: 1US FAERS
393Sense of oppressionFAERS: 1US FAERS
394Seronegative arthritisFAERS: 1US FAERS
395Serum SicknessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
396Similar reaction on previous exposure to drugFAERS: 1US FAERS
397SinusitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
398Skin UlcerFAERS: 1US FAERS
399Skin irritationFAERS: 1US FAERS
400Skin necrosisFAERS: 1US FAERS
401Sleep TalkingFAERS: 1US FAERS
402Slow response to stimuliFAERS: 1US FAERS
403Soft tissue swellingFAERS: 1US FAERS
404Stasis dermatitisFAERS: 1US FAERS
405Stent occlusionFAERS: 1OFFSIDES
US FAERS
406Stevens-Johnson SyndromeFAERS: 1US FAERS
407StridorFAERS: 1US FAERS
408Stroke in evolutionFAERS: 1US FAERS
409StuporFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
410Sudden Cardiac DeathFAERS: 1US FAERS
411Supraventricular tachycardiaFAERS: 1US FAERS
412Therapeutic product contaminationFAERS: 1US FAERS
413Therapeutic product cross-reactivityFAERS: 1US FAERS
414Thermal burnFAERS: 1US FAERS
415ThrombocytopeniaFAERS: 1US FAERS
416Thrombosis in deviceFAERS: 1US FAERS
417Tongue bitingFAERS: 1US FAERS
418Tongue erythemaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
419Tracheal StenosisFAERS: 1US FAERS
420Tryptase increasedFAERS: 1US FAERS
421Upper airway obstructionFAERS: 1US FAERS
422Upper respiratory tract congestionFAERS: 1US FAERS
423VIIth nerve paralysisFAERS: 1US FAERS
424Vascular painFAERS: 1US FAERS
425Vein collapseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
426Venous ThrombosisFAERS: 1US FAERS
427Venous thrombosis limbFAERS: 1US FAERS
428Visual disturbanceFAERS: 1US FAERS
429Weaning failureFAERS: 1US FAERS
430Weight decrease neonatalFAERS: 1US FAERS
431White blood cell count decreasedFAERS: 1US FAERS
432muscle injuryFAERS: 1US FAERS
433nervous system disorderFAERS: 1SIDER
US FAERS
434Abdominal Compartment SyndromeOFFSIDES
435AgraphiaOFFSIDES
436Albuminuria6267894
9419624
CTD
437Amnesia, Transient Global1603313CTD
438Amylase increasedSIDER
439Angina Pectoris8213508
9408613
11578707
CTD
440Arterial thrombosisCanada Vigilance: 2Canada Vigilance
441ArthritisSIDER
442Aseptic MeningitisOFFSIDES
443Blood amylase increasedSIDER
444Blood uric acidOFFSIDES
445Body TemperatureOFFSIDES
446Brain Diseases9522916CTD
447Cerebral Hemorrhage20360541CTD
448CholangiolitisOFFSIDES
449Color blindnessOFFSIDES
450Concomitant disease progressionOFFSIDES
451ConjunctivitisCanada Vigilance: 2Canada Vigilance
452Disease recurrenceOFFSIDES
453DiverticulitisOFFSIDES
454Drug withdrawal headacheOFFSIDES
455Dyspnea8761866
11578707
CTD
456DystoniaOFFSIDES
457Edema2217792CTD
458EmbolismCanada Vigilance: 1Canada Vigilance
459Eosinophilic PneumoniaOFFSIDES
460Epidural AbscessOFFSIDES
461Exfoliative rashOFFSIDES
462Extremity contractureOFFSIDES
463Fever15261325CTD
464FibromyalgiaCanada Vigilance: 1Canada Vigilance
465FlatulenceSIDER
466Gastrointestinal PainSIDER
467Gaze palsyOFFSIDES
468Gingival pruritusOFFSIDES
469Heart Diseases2353655CTD
470Hyperosmolar stateOFFSIDES
471HyperventilationCanada Vigilance: 5Canada Vigilance
OFFSIDES
472Injection site massCanada Vigilance: 1Canada Vigilance
473Intention tremorOFFSIDES
474Intracranial Embolism and Thrombosis7833172CTD
475Kidney Diseases

View details

CTD
476LaryngitisCanada Vigilance: 1Canada Vigilance
477LightheadednessSIDER
478Lip pruritusCanada Vigilance: 2Canada Vigilance
479Long QT Syndrome15206999CTD
480MeningismSIDER
481Meningoencephalitis19039046CTD
482Muscle WeaknessOFFSIDES
483Musculoskeletal chest painCanada Vigilance: 1Canada Vigilance
484Musculoskeletal discomfortSIDER
485Nephrogenic Fibrosing DermopathyOFFSIDES
486Nephrosis1967501CTD
487Nephrotic SyndromeOFFSIDES
488Neurotoxicity Syndromes17565207CTD
489Neutrophil count decreasedOFFSIDES
490Ocular icterusOFFSIDES
491Oral mucosal erythemaCanada Vigilance: 2Canada Vigilance
492Oropharyngeal spasmCanada Vigilance: 1Canada Vigilance
493Pancreatic carcinoma recurrentOFFSIDES
494Pharyngeal swellingCanada Vigilance: 25Canada Vigilance
495PhotophobiaCanada Vigilance: 2Canada Vigilance
SIDER
496Portal Vein ThrombosisOFFSIDES
497PremedicationCanada Vigilance: 1Canada Vigilance
498PsoriasisCanada Vigilance: 1Canada Vigilance
499Pulmonary Edema8213508CTD
500Pulmonary congestionCanada Vigilance: 1Canada Vigilance
501Reaction gastrointestinalSIDER
502Renal Insufficiency9169676
18256017
CTD
503RhinitisCanada Vigilance: 5Canada Vigilance
504RhinorrheaOFFSIDES
505Secretion dischargeOFFSIDES
506Seizures

View details

CTD
507Skin IndurationOFFSIDES
508StomatitisCanada Vigilance: 1Canada Vigilance
509Subarachnoid Hemorrhage1603313CTD
510Swelling of eyelidCanada Vigilance: 9Canada Vigilance
511Tachycardia, Ventricular15206999CTD
512Thromboembolism11108904CTD
513ThrombophlebitisSIDER
514ThyrotoxicosisSIDER
515Toxicity to various agentsSIDER
516UnwellSIDER
517Vasospasm, Intracranial1603313CTD
518Ventricular hypokinesiaSIDER
519anaphylaxis12009227
16518532
CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.